Cargando…
Osteoprotegerin: Relationship to Breast Cancer Risk and Prognosis
Osteoprotegerin (OPG) is a secreted member of the Tumor Necrosis Factor (TNF) receptor superfamily (TNFRSF11B), that was first characterized and named for its protective role in bone remodeling. In this context, OPG binds to another TNF superfamily member Receptor Activator of NF-kappaB Ligand (RANK...
Autores principales: | Geerts, Dirk, Chopra, Christina, Connelly, Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154067/ https://www.ncbi.nlm.nih.gov/pubmed/32318347 http://dx.doi.org/10.3389/fonc.2020.00462 |
Ejemplares similares
-
Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis
por: Weichhaus, Michael, et al.
Publicado: (2014) -
Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells
por: Chung, Stephanie Tsang Mui, et al.
Publicado: (2017) -
Editorial: The Tumor Necrosis Factor Superfamily: An Increasing Role in Breast Cancer
por: Geerts, Dirk, et al.
Publicado: (2020) -
Osteoprotegerin in breast cancer: beyond bone remodeling
por: Weichhaus, Michael, et al.
Publicado: (2015) -
Prognostic Value of Serum Osteoprotegerin Level in Patients With Hepatocellular Carcinoma Following Surgical Resection
por: Zhang, Chihao, et al.
Publicado: (2021)